{"id": "chatcmpl-B2Ed4Gc1KW8J9ojLMwKx3TItcpqx1", "object": "chat.completion", "created": 1739872590, "model": "gpt-4o-mini-2024-07-18", "choices": [{"index": 0, "message": {"role": "assistant", "content": null, "function_call": {"name": "get_emergingtechnologies", "arguments": "{\"technology\":[{\"name\":\"MDMA-Assisted Therapy\",\"description\":\"The use of MDMA for therapeutic purposes, particularly in treating post-traumatic stress disorder under medical supervision.\",\"relevancy\":5},{\"name\":\"Psilocybin-Assisted Therapy\",\"description\":\"The therapeutic use of psilocybin for treating treatment-resistant depression and other psychiatric disorders.\",\"relevancy\":5},{\"name\":\"Psychedelic Research Infrastructure\",\"description\":\"Establishing frameworks and protocols for studying psychedelics' effects in medicine and therapy.\",\"relevancy\":4},{\"name\":\"Psychedelic-Assisted Psychotherapy\",\"description\":\"Integrating psychedelics into psychotherapy under controlled settings for enhanced mental health treatments.\",\"relevancy\":4},{\"name\":\"Regulatory Approvals for Psychedelic Use\",\"description\":\"Processes for approving the medical use of psychedelics, ensuring safety and ethics in treatments.\",\"relevancy\":5},{\"name\":\"Training Programs for Therapists\",\"description\":\"Specialized training for therapists to safely administer psychedelic-assisted therapies.\",\"relevancy\":4}]}"}, "refusal": null}, "logprobs": null, "finish_reason": "function_call"}], "usage": {"prompt_tokens": 998, "completion_tokens": 227, "total_tokens": 1225, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 0, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": "fp_00428b782a"}